Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication

Journal of Viral Hepatitis

Volumn 13, Issue 3, 2006, Pages 158-165

  Yang, J ^a   Bo, X C ^a   Ding, X R ^a   Dai, J M ^a   Zhang, M L ^a   Wang, X H ^a   Wang, S Q ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Antisense oligonucleiotides; Asialoglycoprotein receptor 1; Hepatitis B virus

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ASIALOGLYCOPROTEIN RECEPTOR; ASIALOGLYCOPROTEIN RECEPTOR 1; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; LIPOFECTIN; MESSENGER RNA; UNCLASSIFIED DRUG; VIRUS DNA;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL VIABILITY; CHRONIC HEPATITIS; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; VIRUS ADSORPTION; VIRUS INHIBITION; VIRUS REPLICATION; WESTERN BLOTTING;

ANTIVIRAL AGENTS; ASIALOGLYCOPROTEIN RECEPTOR; CELL LINE; CELL SURVIVAL; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, VIRAL; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

EID: 33645099764     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2005.00666.x     Document Type: Article

References (28)

1. Seeger C Mason WS Hepatitis B virus biology Microbiol Mol Biol Rev 2000 64 1 51 68
2. Liu J Li YH Xue CF et al. Targeted ribonuclease can inhibit replication of hepatitis B virus World J Gastroenterol 2003 9 2 295 299
3. Lau JY Wright TL Molecular virology and pathogenesis of hepatitis B Lancet 1993 342 1335 1340
4. Parkin DM Pisani P Munoz N Ferlay J The global health burden of infection associated cancers Cancer Surv 1999 33 5 33
5. Colledge D Civitico G Locarnini S Shaw T In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir Antimicrob Agents Chemother 2000 44 3 551 560
6. Fuhrer C Geffen I Huggel K Spiess M The two subunits of the asialoglycoprotein receptor contain different sorting information J Biol Chem 1994 269 5 3277 3282
7. Spiess M The asialoglycoprotein receptor: a model for endocytic transport receptors Biochemistry 1990 29 43 10009 10018
8. Paietta E Stockert RJ Racevskis J Differences in the abundance of variably spliced transcripts for the second asialoglycoprotein receptor polypeptide, H2, in normal and transformed human liver Hepatology 1992 15 3 395 402
9. Yang J Bo XC Yao J Yang NM Wang SQ Differentially expressed cellular genes following HBV:potential targets of anti-HBV drugs J Viral Hepat 2005 12 357 363
10. Wu GY Zhang P Rowell RJ Wu CH Modication of inactivated adenovirus with a targetable DNA carrier enhances foreign gene expression in vitro and in vivo Hepatology 1992 16 112
11. Treichel U Buschenfelde KHMZ Stockert RJ et al. The asialoglycoprotein recertor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic crriers J Gen Virol 1994 75 3021 3029
12. Treichel U Buschenfelde KHMZ Gerken G et al. Receptor-mediated entry of hepatitis B virus particles into liver cells Arch Virol 1997 142 493 498
13. Taylor MF Wiederholt K Sverdrup F Antisense oligonucleotides: a systematic high-throughput approach to target validation and gene function determination Drug Discov Today 1999 4 12 562 567
14. Zuker M Mfold web server for nucleic acid folding and hybridization prediction Nucleic Acids Res 2003 31 13 3406 3415
15. Patzel V Steidl U Kronenwett R Haas R Sczakiel G A theoretical approach to select effective antisense oligodeoxyribonucleotides at high statistical probability Nucleic Acids Res 1999 27 22 4328 4334
16. Uhlmann E Peyman A Ryte A Schmidt A Buddecke E Use of minimal modified antisense oligonucleotides for specific inhibition of gene expression Methods Enzymol 1999 313 268 284
17. Cohen JS Oligonucleotide therapy In Crooke ST Lebleu B eds Antisense Research and Applications
18. Sells MA Zelent AZ Shvartsman M Acs G Replication hepatitis B virus in HepG2 cells that produce infectious virions J Virol 1988 62 2836 2844
19. Sells MA Chen ML Acs G Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA Proc Natl Acad Sci USA 1987 84 4 1005 1009
20. He YY Wang SQ Chen SH et al. Construction and clinical application of a new fluorescent quantitative polymerase chain reaction technique for HBV detection Chin J Hepatol 2001 9 6 376 377
21. Wang SQ Wang XH Chen SH et al. A new fluorescent quantitative polymerase chain reaction technique Anal Biochem 2002 309 2 206 211
22. Woolf TM Melton DA Jennings CG Specificity of antisense oligonucleotides in vivo Proc Natl Acad Sci USA 1992 89 16 7305 7309
23. Raney AK Hamatake RK Hong Z Agents in clinical development for the treatment of chronic hepatitis B Expert Opin Investig Drugs 2003 12 8 1281 1295
24. Greenberg HB Pollard RB Lutwick LI Gregory PB Robinson WS Merigan TC Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis N Engl J Med 1976 295 517 522
25. Asmuth DM Nguyen HH Melcher GP Cohen SH Pollard RB Treatments for hepatitis B Clin Infect Dis 2004 39 9 1353 1362
26. Wagner RW Flanagan WM Antisense technology and prospects for therapy of viral infections and cancer Mol Med Today 1997 3 1 31 38
27. Marwick C First ''antisense'' drug will treat CMV retinitis JAMA 1998 280 10 871
28. Stix G Shutting down a gene. Antisense drug wins approval Sci Am 1998 279 5 46 50